Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 4 | 5 | 3 | 4 | 3 | 4 | 6 | 8 | 3 | 2 | 5 | 5 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Deferred Offering Costs | - | - | 0 | - | - | - | - | - | - | 0 | - | - | |||||
Assets Held For Sale Not Part Of Disposal Group Cu… | 0 | 0 | - | - | - | - | - | - | - | - | - | - | |||||
Assets Current | 4 | 5 | 3 | 5 | 4 | 5 | 7 | 9 | 3 | 3 | 7 | 7 | |||||
Property Plant And Equipment Net | 2 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Assets | 6 | 7 | 5 | 6 | 5 | 7 | 8 | 11 | 5 | 5 | 8 | 8 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accounts Payable And Other Accrued Liabilities Cur… | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | |||||
Notes Payable Current | - | - | - | - | - | - | - | 0 | - | - | - | - | |||||
Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | |||||
Operating Lease Liability Noncurrent | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 3 | 2 | |||||
Stockholders Equity | |||||||||||||||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 48 | 47 | 44 | 44 | 40 | 40 | 40 | 40 | 33 | 30 | 30 | 29 | |||||
Retained Earnings Accumulated Deficit | -43 | -42 | -40 | -38 | -37 | -35 | -33 | -32 | -29 | -27 | -25 | -22 | |||||
Stockholders Equity | 4 | 6 | 4 | 5 | 4 | 6 | 7 | 9 | 3 | 3 | 5 | 6 | |||||
Liabilities And Stockholders Equity | 6 | 7 | 5 | 6 | 5 | 7 | 8 | 11 | 5 | 5 | 8 | 8 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 250 | 250 | 250 | 250 | 250 | 250 | 250 | 300 | 300 | 11 | 13 | 13 | |||||
Common Stock Shares Issued | 2 | 2 | 2 | 1 | 1 | 1 | 100 | 97 | 101 | 116 | 2,788 | 2,303 | |||||
Shares Outstanding | 14 | 15 | 15 | 15 | 17 | 17 | 18 | 18 | 19 | 19 | 19 | 18 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 17.58% | 60.99% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 24.31% | -9.94% | -17.13% | -7.41% | 1.36% | 57.14% | -17.20% | -55.41% | -47.77% | 5.38% | 2.10% | 3.23% |
| 2024 | -17.52% | -85.81% | -86.90% | -49.66% | -55.03% | -71.81% | -24.73% | -22.15% | -4.52% | -55.23% | -51.47% | -58.18% |
| 2023 | -18.67% | -12.33% | 30.50% | -44.37% | -49.42% | -52.52% | 2.22% | -61.27% | -75.56% | -31.51% | -27.77% | -36.49% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.81 | 4.88 | 2.92 | 4.56 | 2.71 | 6.05 | 6.26 | 4.38 | 2.26 | 1.82 | 2.33 | 3.59 | |||||
| Quick Ratio | 2.62 | 4.64 | 2.77 | 4.27 | 2.37 | 5.31 | 5.49 | 3.92 | 1.74 | 1.40 | 1.81 | 2.78 | |||||
| Working Capital | 2.55M | 4.34M | 2.20M | 3.71M | 2.26M | 4.09M | 5.52M | 6.96M | 1.92M | 1.45M | 3.73M | 4.75M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.34 | 0.19 | 0.32 | 0.21 | 0.37 | 0.16 | 0.17 | 0.26 | 0.51 | 0.68 | 0.58 | 0.33 | |||||
| Interest Coverage TTM | -8,346.71 | -8,287.21 | -1,095.28 | -34.15 | -8.06 | -8.71 | -9.88 | -14.45 | - | - | - | - | |||||
| Debt Ratio | 0.25 | 0.16 | 0.24 | 0.17 | 0.27 | 0.14 | 0.14 | 0.20 | 0.34 | 0.41 | 0.37 | 0.25 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -7.01 | -7.63 | -8.70 | -28.78 | -29.57 | -30.45 | -30.43 | -12.98 | -11.01 | -11.26 | -11.28 | -12.97 | |||||
| Free Cash Flow Per Share TTM | -6.58 | -6.74 | -7.69 | -9.87 | -10.07 | -11.82 | -13.31 | -11.85 | -9.13 | -10.20 | -10.49 | -12.35 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Operating Profit Margin TTM | - | - | - | - | - | - | - | - | - | - | 4,167.24% | - | |||||
| Net Profit Margin TTM | - | - | - | - | - | - | - | - | - | - | 4,030.44% | - | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | - | - | - | - | - | - | -100.00% | - | -100.00% | -100.00% | -150.00% | -100.00% | |||||
| Net Income Growth (1Y) | -66.29% | -67.30% | -68.59% | 112.22% | 110.18% | 110.38% | 117.30% | -12.10% | -0.82% | 7.07% | 9.04% | 43.83% | |||||
| EPS Growth (1Y) | -76.29% | -74.96% | -71.41% | 121.75% | 168.51% | 170.48% | 169.70% | 0.07% | -7.90% | -1.55% | -0.39% | 41.59% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -0.26 | -0.35 | -0.70 | -0.24 | -0.50 | -0.64 | -0.83 | -10.77 | -116.67 | -173.39 | -613.94 | -648.97 | |||||
| P/B TTM | 0.43 | 0.40 | 1.30 | 0.90 | 2.67 | 2.34 | 2.54 | 11.72 | 337.57 | 596.21 | 1,182.08 | 1,088.95 | |||||
| P/S TTM | - | - | - | - | - | - | - | - | - | - | -24,744.57 | - | |||||
| Market Cap | 1.81M | 2.40M | 4.79M | 4.77M | 10.33M | 13.40M | 18.20M | 101.32M | 1.14B | 1.73B | 6.16B | 6.94B | |||||
| Enterprise Value | -1.87M | -2.77M | 1.70M | 328.61K | 7.22M | 9.09M | 12.45M | 93.41M | 1.13B | 1.72B | 6.16B | 6.94B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -6.48M | -6.05M | -6.05M | -6.85M | -6.98M | -8.13M | -9.54M | -8.59M | -8.08M | -9.02M | -9.34M | -10.19M | |||||
| Net Debt | -3.68M | -5.16M | -3.08M | -4.44M | -3.12M | -4.30M | -5.76M | -7.91M | -2.66M | -2.21M | -5.08M | -5.10M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
Bluejay Diagnostics, Inc. (BJDX) — SEC Financial Statements & Analysis
Bluejay Diagnostics, Inc. (BJDX) is a surgical & medical instruments & apparatus company, incorporated in DE. Bluejay Diagnostics, Inc. trades on Nasdaq as: BJDX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Bluejay Diagnostics, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of 0.34x, a Price-to-Sales (P/S) ratio of -24744.57x (TTM), a Price-to-Book (P/B) ratio of 0.43 (TTM), at a market cap of $1.81M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- -100.00%
- Debt To Equity
- 0.34x
- P/S TTM
- -24744.57x
- P/B TTM
- 0.43
- Market Cap
- $1.81M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Bluejay Diagnostics, Inc. in?
Bluejay Diagnostics, Inc. (BJDX) operates in the Surgical & Medical Instruments & Apparatus industry.
What is BJDX's market cap?
Bluejay Diagnostics, Inc. (BJDX) has a market capitalization of $1.81M as of 2026-03-31.
What exchange does BJDX trade on?
Bluejay Diagnostics, Inc. (BJDX) trades on the Nasdaq.
Where is Bluejay Diagnostics, Inc. incorporated?
Bluejay Diagnostics, Inc. is incorporated in DE.